GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Arecor Therapeutics AREC.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

77.50p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2025

Revenue

£1.7m

FY2018FY2025

Net income

£664,000

FY2018FY2025

Free cash flow

−£2.4m

FY2018FY2025

Shareholders' equity

£6.5m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue£1.7m£5.1m£4.6m£2.4m£1.2m£1.7m£747,672£1.4m
Research and development£2.7m£3.0m£6.0m£8.6m£5.4m£3.9m£3.1m£2.3m
Operating income−£4.7m−£10.7m−£9.2m−£11.7m−£6.0m−£3.4m−£2.9m−£1.4m
Net income£664,000−£10.2m−£8.6m−£9.3m−£6.2m−£2.8m−£2.4m−£1.1m
Diluted earnings per share0.02-0.27-0.28-0.31-0.22-0.10-0.09-0.04

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets£8.1m£8.7m£15.4m£21.8m£20.9m£4.3m£5.5m£2.1m
Cash and short-term investments£6.1m£3.3m£6.8m£12.8m£18.3m£2.9m£3.4m£704,942
Total liabilities£1.6m£3.4m£5.8m£4.3m£2.4m£3.5m£1.2m£1.4m
Debt£98,000£232,000£338,000£288,000£231,000£2.0m£221,274£660,093
Shareholders' equity£6.5m£5.3m£9.5m£17.5m£18.5m£773,787£4.2m£670,333
Shares outstanding39m38m31m30m28m28m28m28m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−£2.3m−£9.2m−£5.8m−£10.8m−£5.5m−£1.9m−£2.5m−£492,571
Capital spending−£99,000−£23,000−£151,000−£345,000−£69,000−£52,294−£73,133−£12,918
Free cash flow−£2.4m−£9.2m−£6.0m−£11.1m−£5.5m−£1.9m−£2.6m−£505,489

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue£194,000−£289,000£2.0m£3.1m£2.0m£997,500£2.9m£1.5m
Operating income−£3.3m−£1.5m−£3.1m−£2.8m−£7.9m−£2.4m−£3.6m−£2.1m
Net income−£3.0m£3.2m−£2.5m−£5.6m−£4.6m−£2.3m−£4.0m−£2.0m
Diluted earnings per share-0.080.08-0.06-0.15-0.12-0.06-0.13-0.07
Cash from operations−£3.0m−£1.0m−£1.0m−£4.0m−£4.0m−£2.0m−£1.0m—
Total assets£4.7m£8.1m£5.3m£8.7m£10.4m£10.4m£15.4m£15.4m
Cash and short-term investments£3.2m£6.1m£1.9m£3.3m£2.5m£2.5m£6.8m£6.8m
Debt£52,000£192,000£114,000£121,000£111,000£111,000£118,000£118,000
Shareholders' equity£3.7m£6.5m£2.9m£5.3m£5.1m£5.1m£9.5m£9.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.7%0.2%—
Operating income-26.3%6.4%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings47.8-2.7-6.5-7.8-18.1
Price to sales18.55.512.230.096.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.